549 related articles for article (PubMed ID: 11014433)
21. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
22. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.
Huang Q; Pu P; Xia Z; You Y
J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907
[TBL] [Abstract][Full Text] [Related]
23. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.
Rogulski KR; Wing MS; Paielli DL; Gilbert JD; Kim JH; Freytag SO
Hum Gene Ther; 2000 Jan; 11(1):67-76. PubMed ID: 10646640
[TBL] [Abstract][Full Text] [Related]
24. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
25. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated double suicide gene selectively kills gastric cancer cells.
Luo XR; Li JS; Niu Y; Miao L
Asian Pac J Cancer Prev; 2012; 13(3):781-4. PubMed ID: 22631647
[TBL] [Abstract][Full Text] [Related]
27. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
28. Suicide gene therapy on LNCaP human prostate cancer cells.
Yoshimura I; Suzuki S; Tadakuma T; Hayakawa M
Int J Urol; 2001 Jul; 8(7):S5-8. PubMed ID: 11442669
[TBL] [Abstract][Full Text] [Related]
29. Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells.
Glaser T; Castro MG; Löwenstein PR; Weller M
Gene Ther; 2001 Mar; 8(6):469-76. PubMed ID: 11313826
[TBL] [Abstract][Full Text] [Related]
30. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
Chen SH; Shine HD; Goodman JC; Grossman RG; Woo SL
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3054-7. PubMed ID: 8159705
[TBL] [Abstract][Full Text] [Related]
32. [Suicide gene therapy for glioma using HSV-tk/GCV system].
Xu L; Ge K; Zheng Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
[TBL] [Abstract][Full Text] [Related]
33. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
[TBL] [Abstract][Full Text] [Related]
35. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
[TBL] [Abstract][Full Text] [Related]
36. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
37. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.
Shirakawa T; Gardner TA; Ko SC; Bander N; Woo S; Gotoh A; Kamidono S; Chung LW; Kao C
J Urol; 1999 Sep; 162(3 Pt 1):949-54. PubMed ID: 10458414
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
[TBL] [Abstract][Full Text] [Related]
40. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
